Monkey menace triggers panic at Melur GH in Madurai, authorities say patients feeding them
MADURAI: Patients and attendants at the Melur Government Hospital in Madurai district continue to face persistent trouble from groups of monkeys that have been invading the hospital premises for years, triggering fear and frustration among the public.
The monkeys, believed to have migrated from forest areas near Alagarkoil, have become a common sight in the hospital, especially during late mornings. Patients allege that despite multiple rescue operations, the monkeys continue to return in groups, creating panic.
"Every day, monkeys roam freely around the hospital wards. They feed on garbage and even when no food is available, they leap from floor to floor, unsettling patients. They often arrive between 10 am and 12 pm, and behave as if we are the intruders in their territory," said Vijayamohan, a patient attender.
Sathyamoorthy, a resident who frequently visits the hospital's 24-hour maternal care centre with his wife, echoed similar concerns. "The monkeys try to snatch bags and belongings. Only when staff or sanitary workers arrive with sticks do they retreat. Though they haven't attacked anyone so far, their presence is intimidating. Even after being caught once, they return and are now seen across all blocks of the hospital," he said.
A top official from the Melur GH confirmed that while no bite incidents have been reported, the hospital staff, including doctors, are alarmed. "We spent over Rs 40,000 to purchase cages, and the forest department helped relocate several monkeys to deep forest areas. The problem subsided for a few months, but has returned. Some patients continue to offer food, which attracts the animals. We have warned them against feeding," the official added.
District Forest Officer (Madurai) Tarun Kumar said that the department has repeatedly rescued monkeys from Alagarkoil and nearby areas. "Even after relocation, they tend to return to urban pockets like Melur due to continued feeding by the public. We have seen individuals feeding monkeys behind the hospital, which only worsens the situation. We will soon launch an awareness campaign to educate the public and discuss preventive strategies in upcoming district-level monitoring meetings," he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
39 minutes ago
- Economic Times
Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare
Fortis Healthcare is poised for robust growth, driven by hospital expansion and a turnaround in its diagnostics business. With plans to add 900+ beds and expectations of 14–15% revenue growth in FY26, analysts remain bullish. Brownfield expansions and improving ARPOB are likely to support margin improvement and top-line growth. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Shares of Fortis Healthcare has risen 11% in three months, outperforming the 2.3% gain in the ET Pharma index. The company registered decent earnings in the March 2025 quarter. It plans to add around 900 beds next year. It expects revenue to grow by 14-15% for FY26 along with 150-200 basis point margin expansion, driven by better occupancy. Analysts have maintained an 'Outperform' rating on the company had 4,750 operational beds, including operations and management (O&M) contracts, as of March 2025. It aims for 20% additional capacity, which is 900-1,000 beds by FY26 and another 1,000 by February 2025, Fortis Healthcare's wholly owned subsidiary, Fortis Hospotel , acquired Shrimann Superspecialty Hospital in Jalandhar, which had 220 beds. The company has received an occupancy certificate (OC) for 150 beds in Noida, which will be operational soon. A 200-bed facility will be opened in Manesar, a 220-bed expansion in Fortis Memorial Research Institute and another 140-bed facility in BG Road, for which OC is the March 2025 quarter, revenue grew 12.4% year-on-year to Rs2,007.2 crore, driven by strong momentum in the hospital business, which constituted 85% of the revenue. The hospital segment recorded 14% YoY revenue growth, supported by a 5.5% increase in occupancy rates and an 8.4% rise in the average revenue per occupied bed (ARPOB) while the performance of the diagnostics division remained subdued amid a rebranding EBITDA margin improved by 40 basis points year-on-year to 21.7%. However, the net profit fell by 26.1% to Rs 188 crore due to a one-off impairment charge of Rs 53.6 diagnostics segment, which was rebranded to Agilus from SRL two years ago, remains a work in progress with just 3% year-on-year increase in revenue in the March quarter. Fortis expects a stronger performance from FY26, given that the exercise of brand transitioning and costs related to it are now behind. It expects double-digit revenue growth for the division with a 23-25% margin in a couple of years. BNP Paribas has maintained 'Outperform' on Fortis, raising the hospital segment's EBITDA estimate by 3% for FY26-28. JM Financial expects Fortis to show the strongest ARPOB growth , driven by brownfield expansions and increased metro presence. 'With the on-going efforts to improve the profitability of underperforming units, combined with significant brownfield expansion, the company is poised to achieve over 15% topline growth over the next three years, along with 200-300 bps margin (improvement)', JM Financial said in a report.
Time of India
42 minutes ago
- Time of India
Hospital business, improving diagnostics segment to drive growth for Fortis Healthcare
Shares of Fortis Healthcare has risen 11% in three months, outperforming the 2.3% gain in the ET Pharma index. The company registered decent earnings in the March 2025 quarter. It plans to add around 900 beds next year. It expects revenue to grow by 14-15% for FY26 along with 150-200 basis point margin expansion, driven by better occupancy. Analysts have maintained an 'Outperform' rating on the stock. The company had 4,750 operational beds, including operations and management (O&M) contracts, as of March 2025. It aims for 20% additional capacity, which is 900-1,000 beds by FY26 and another 1,000 by FY27. In February 2025, Fortis Healthcare's wholly owned subsidiary, Fortis Hospotel , acquired Shrimann Superspecialty Hospital in Jalandhar, which had 220 beds. The company has received an occupancy certificate (OC) for 150 beds in Noida, which will be operational soon. A 200-bed facility will be opened in Manesar, a 220-bed expansion in Fortis Memorial Research Institute and another 140-bed facility in BG Road, for which OC is expected. In the March 2025 quarter, revenue grew 12.4% year-on-year to Rs2,007.2 crore, driven by strong momentum in the hospital business, which constituted 85% of the revenue. The hospital segment recorded 14% YoY revenue growth, supported by a 5.5% increase in occupancy rates and an 8.4% rise in the average revenue per occupied bed (ARPOB) while the performance of the diagnostics division remained subdued amid a rebranding exercise. Consolidated EBITDA margin improved by 40 basis points year-on-year to 21.7%. However, the net profit fell by 26.1% to Rs 188 crore due to a one-off impairment charge of Rs 53.6 crore. Live Events The diagnostics segment, which was rebranded to Agilus from SRL two years ago, remains a work in progress with just 3% year-on-year increase in revenue in the March quarter. Fortis expects a stronger performance from FY26, given that the exercise of brand transitioning and costs related to it are now behind. It expects double-digit revenue growth for the division with a 23-25% margin in a couple of years. BNP Paribas has maintained 'Outperform' on Fortis, raising the hospital segment's EBITDA estimate by 3% for FY26-28. JM Financial expects Fortis to show the strongest ARPOB growth , driven by brownfield expansions and increased metro presence. 'With the on-going efforts to improve the profitability of underperforming units, combined with significant brownfield expansion, the company is poised to achieve over 15% topline growth over the next three years, along with 200-300 bps margin (improvement)', JM Financial said in a report.
Time of India
3 hours ago
- Time of India
Chhattisgarh set to become national, international centre for Ayurveda: CM Sai
Durg: Chhattisgarh, which has a rich forest cover, is poised to become a national and international centre for Ayurveda, Chief Minister Vishnu Deo Sai said on Sunday. He was speaking after inaugurating an advanced Ayurvedic medicine processing facility and central warehouse complex at Jamgaon in Durg district. The unit, developed by the Chhattisgarh State Minor Forest Produce Cooperative Federation, will also have a herbal extraction set-up established through a public-private partnership with Sprayer Biotech Private Limited, he said. The CM said the unit is expected to generate 2,000 direct and indirect jobs. "With nearly 44 per cent of Chhattisgarh's landmass under forest cover, this initiative is both a privilege and a responsibility. The raw materials for Ayurvedic formulations will be sustainably sourced from our forests, ensuring tangible economic benefits for tribal communities," he said. He described the processing unit as the largest of its kind in Central India and a milestone that will enhance healthcare delivery while positioning Chhattisgarh as a recognised national and international centre of Ayurveda. The CM said that the state government is steadfastly fulfilling the guarantees made by Prime Minister Narendra Modi. "Over the past 18 months, we have been resolutely advancing the state's development agenda. Every promise made to the 3 crore citizens of Chhattisgarh is being honoured with utmost priority," Sai said. He said the government's decision to hike the procurement rate for tendu leaves from Rs 4,500 to Rs 5,500 per standard sack is benefiting nearly 1.3 million tendu leaf collector families. He also highlighted the revival of the 'Charan Paduka Yojana', under which protective footwear is distributed to forest workers. Five women beneficiaries received footwear during the event. Appealing to citizens to participate in the 'Ek Ped Maa Ke Naam' (One Tree in Mother's Name) campaign, the CM urged every individual to plant at least one sapling as a tribute to their mother and nature. Forest Minister Kedar Kashyap, who also attended the event, called the facility a vital step towards streamlining the collection, processing, and marketing of forest resources. He said that the state collects 67 varieties of minor forest produce, benefitting over 1.34 million forest-dependent families. The Ayurvedic processing unit reflects the efforts to integrate Chhattisgarh's abundant forest resources with modern scientific techniques, realising the 'Forest to Pharmacy' model, he said. Built over 27.87 acres at Rs 36.47 crore, the facility is projected to produce Rs 50 crore Ayurvedic products annually, said officials. Medicinal and minor forest produce like mahua, sal seeds, kalmegh, giloy, and ashwagandha will be processed into powders, syrups, oils, tablets, and avaleha under stringent quality standards, they said. The unit will also serve as a key hub for promoting the 'Chhattisgarh Herbals' brand across national and international markets. Technical training programmes will enable local youth to acquire skills and access new avenues of employment, they said. A modern warehouse with a capacity of 20,000 metric tonnes has also been constructed to facilitate long-term storage and quality control of seasonal produce. The initiative embodies PM Modi's vision of 'Vocal for Local' and 'Atmanirbhar Bharat', they added. PTI
